Literature DB >> 16797400

Surrogate markers in clinical studies: problems solved or created?

Braden Manns, William F Owen, Wolfgang C Winkelmayer, P J Devereaux, Marcello Tonelli.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16797400     DOI： 10.1053/j.ajkd.2006.03.044

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  5 in total

Review 1.  Optimizing the use of prescription drugs in Canada through the Common Drug Review.

Authors:  Mike Tierney; Braden Manns
Journal:  CMAJ       Date:  2008-02-12       Impact factor: 8.262

2.  Cost-effectiveness of blood glucose test strips in the management of adult patients with diabetes mellitus.

Authors: 
Journal:  CADTH Technol Overv       Date:  2010-06-01

3.  The new FDA labeling for ESA--implications for patients and providers.

Authors:  Braden J Manns; Marcello Tonelli
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 8.237

Review 4.  Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials.

Authors:  Qian Shi; Daniel J Sargent
Journal:  Int J Clin Oncol       Date:  2009-04-24       Impact factor: 3.402

5.  Health care prioritization: a clinician's duty.

Authors:  Lianne Barnieh; Cam Donaldson; Braden Manns
Journal:  Can J Kidney Health Dis       Date:  2014-10-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.